Inventor · disambiguated record
Thomas Wolfel
Also filed as: WOELFEL THOMAS · WOLFEL THOMAS · WÖLFEL THOMAS
15 granted patents·2 pending applications·279 citations·filing 1993–2015
94Inventor score
Files withLUDWIG INST CANCER RES14EBERTS DANIELA1Johannes Gutenberg-Universität Mainz1UNIV MAINZ JOHANNES GUTENBERG1
Top patents by PatentIndex Score
17 records- 0188US8349558B2Detection of individual T-cell reaction patterns against tumor-associated antigens (TAA) in tumor patients as a basis for the individual therapeutic vaccination of patientsUNIV MAINZ JOHANNES GUTENBERG·Filed 2007·Granted Jan 8, 2013·24 cites·13 claims
- 0279US6669946B2Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individualsLUDWIG INST CANCER RES·Filed 2001·Granted Dec 30, 2003·5 cites·1 claims
- 0379US5487974AMethod for detecting complexes containing human leukocyte antigen A2 (HLA-A2) molecules and a tyrosinase drived peptide on abnormal cellsLUDWIG INST CANCER RES·Filed 1993·Granted Jan 30, 1996·59 cites·6 claims
- 0473US5747271AMethod for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of HLA-A2/tyrosinase derived peptides, and methods for treating said individualsLUDWIG INST CANCER RES·Filed 1996·Granted May 5, 1998·39 cites·2 claims
- 0569US6201111B1Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursorsLUDWIG INST CANCER RES·Filed 1999·Granted Mar 13, 2001·15 cites·1 claims
- 0669US5856091AIsolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2LUDWIG INST CANCER RES·Filed 1995·Granted Jan 5, 1999·16 cites·21 claims
- 0769US5744316AIsolated, tyrosinase derived peptides and uses thereofLUDWIG INST CANCER RES·Filed 1996·Granted Apr 28, 1998·28 cites·10 claims
- 0866US5854203ATumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2LUDWIG INST CANCER RES·Filed 1995·Granted Dec 29, 1998·25 cites·2 claims
- 0966US5530096AIsolated, tyrosinase derived peptides and uses thereofLUDWIG INST CANCER RES·Filed 1994·Granted Jun 25, 1996·22 cites·1 claims
- 1057US5837476AMethods for determining disorders by assaying for a non-tyrosinase, tumor rejection antigen precursorLUDWIG INST CANCER RES·Filed 1998·Granted Nov 17, 1998·19 cites·2 claims
- 1152US6001975APrecursor processed to at least one tumor rejection antigen presented by HLA-A2LUDWIG INST CANCER RES·Filed 1998·Granted Dec 14, 1999·15 cites·1 claims
- 1252US5519117AIsolated, tyrosinase derived peptides and uses thereofLUDWIG INST CANCER RES·Filed 1994·Granted May 21, 1996·10 cites·2 claims
- 1346US2009104186A1Melanoma-associated MHC class I associated oligopeptides and the uses thereofEBERTS DANIELA·Filed 2006·Application pending·0 cites
- 1441US5843688AIsolated tyrosinase derived peptides and uses thereofLUDWIG INST CANCER RES·Filed 1996·Granted Dec 1, 1998·2 cites·3 claims
- 1540US2015366957A1Melanoma-Associated MHC Class I Associated Oligopeptides and the Uses ThereofJOHANNES GUTENBERG UNIVERSITÄT MAINZ·Filed 2015·Application pending·0 cites
- 1630US5843687AIsolated, tyrosinase derived peptides and uses thereofLUDWIG INST CANCER RES·Filed 1995·Granted Dec 1, 1998·0 cites·7 claims
- 1729US6284476B1Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individualsLUDWIG INST CANCER RES·Filed 1995·Granted Sep 4, 2001·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Wolfel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →